vs
CSW INDUSTRIALS, INC.(CSW)とU S PHYSICAL THERAPY INC(USPH)の財務データ比較。上の社名をクリックして会社を切り替えられます
CSW INDUSTRIALS, INC.の直近四半期売上が大きい($233.0M vs $202.7M、U S PHYSICAL THERAPY INCの約1.1倍)。CSW INDUSTRIALS, INC.の純利益率が高く(4.4% vs 2.0%、差は2.4%)。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い(20.3% vs 12.3%)。CSW INDUSTRIALS, INC.の直近四半期フリーキャッシュフローが多い($22.7M vs $21.0M)。過去8四半期でU S PHYSICAL THERAPY INCの売上複合成長率が高い(14.1% vs 5.1%)
米国フィジカルセラピー社は、米国全土に数百の外来物理療法クリニックを展開する大手リハビリ事業者です。怪我や手術後の回復期の患者、慢性痛や運動障害を抱える人にリハビリケアを提供するほか、スポーツ医学、小児リハビリなどの専門サービスも扱っています。
CSW vs USPH — 直接比較
売上が大きい
CSW
1.1倍大きい
$202.7M
売上成長率が高い
CSW
+8.0%の差
12.3%
純利益率が高い
CSW
純利益率が2.4%高い
2.0%
フリーキャッシュフローが多い
CSW
FCF $1.7M多い
$21.0M
2年売上CAGRが高い
USPH
2年複合成長率
5.1%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $233.0M | $202.7M |
| 純利益 | $10.3M | $4.2M |
| 粗利率 | 39.7% | 19.8% |
| 営業利益率 | 7.4% | 8.3% |
| 純利益率 | 4.4% | 2.0% |
| 売上前年比 | 20.3% | 12.3% |
| 純利益前年比 | -61.9% | -55.1% |
| EPS(希薄化後) | $0.62 | $-0.44 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上
CSW
USPH
| Q4 25 | $233.0M | $202.7M | ||
| Q3 25 | $277.0M | $197.1M | ||
| Q2 25 | $263.6M | $197.3M | ||
| Q1 25 | $230.5M | $183.8M | ||
| Q4 24 | $193.6M | $180.4M | ||
| Q3 24 | $227.9M | $168.0M | ||
| Q2 24 | $226.2M | $167.2M | ||
| Q1 24 | $210.9M | $155.7M |
純利益
CSW
USPH
| Q4 25 | $10.3M | $4.2M | ||
| Q3 25 | $40.7M | $13.1M | ||
| Q2 25 | $40.9M | $12.4M | ||
| Q1 25 | $35.1M | $9.9M | ||
| Q4 24 | $26.9M | $9.2M | ||
| Q3 24 | $36.1M | $6.6M | ||
| Q2 24 | $38.6M | $7.5M | ||
| Q1 24 | $31.8M | $8.0M |
粗利率
CSW
USPH
| Q4 25 | 39.7% | 19.8% | ||
| Q3 25 | 43.0% | 18.7% | ||
| Q2 25 | 43.8% | 21.1% | ||
| Q1 25 | 44.2% | 16.9% | ||
| Q4 24 | 41.4% | 18.0% | ||
| Q3 24 | 45.6% | 17.3% | ||
| Q2 24 | 47.5% | 20.3% | ||
| Q1 24 | 44.4% | 18.2% |
営業利益率
CSW
USPH
| Q4 25 | 7.4% | 8.3% | ||
| Q3 25 | 20.5% | 12.8% | ||
| Q2 25 | 20.8% | 12.6% | ||
| Q1 25 | 19.5% | 10.7% | ||
| Q4 24 | 15.3% | 10.9% | ||
| Q3 24 | 22.6% | 7.6% | ||
| Q2 24 | 24.3% | 9.3% | ||
| Q1 24 | 21.0% | 9.6% |
純利益率
CSW
USPH
| Q4 25 | 4.4% | 2.0% | ||
| Q3 25 | 14.7% | 6.7% | ||
| Q2 25 | 15.5% | 6.3% | ||
| Q1 25 | 15.2% | 5.4% | ||
| Q4 24 | 13.9% | 5.1% | ||
| Q3 24 | 15.8% | 3.9% | ||
| Q2 24 | 17.1% | 4.5% | ||
| Q1 24 | 15.1% | 5.2% |
EPS(希薄化後)
CSW
USPH
| Q4 25 | $0.62 | $-0.44 | ||
| Q3 25 | $2.41 | $0.48 | ||
| Q2 25 | $2.43 | $0.58 | ||
| Q1 25 | $2.05 | $0.80 | ||
| Q4 24 | $1.60 | $0.52 | ||
| Q3 24 | $2.26 | $0.39 | ||
| Q2 24 | $2.47 | $0.47 | ||
| Q1 24 | $2.03 | $0.46 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $35.6M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $1.1B | $476.4M |
| 総資産 | $2.3B | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資
CSW
USPH
| Q4 25 | $40.2M | $35.6M | ||
| Q3 25 | $31.5M | $31.1M | ||
| Q2 25 | $38.0M | $34.1M | ||
| Q1 25 | $225.8M | $39.2M | ||
| Q4 24 | $213.8M | $41.4M | ||
| Q3 24 | $273.2M | $117.0M | ||
| Q2 24 | $18.9M | $112.9M | ||
| Q1 24 | $22.2M | $132.3M |
総負債
CSW
USPH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
株主資本
CSW
USPH
| Q4 25 | $1.1B | $476.4M | ||
| Q3 25 | $1.1B | $503.6M | ||
| Q2 25 | $1.1B | $500.8M | ||
| Q1 25 | $1.1B | $497.3M | ||
| Q4 24 | $1.0B | $488.9M | ||
| Q3 24 | $1.0B | $482.8M | ||
| Q2 24 | $650.2M | $484.6M | ||
| Q1 24 | $615.7M | $479.8M |
総資産
CSW
USPH
| Q4 25 | $2.3B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.1B | $1.0B | ||
| Q1 24 | $1.0B | $1.0B |
負債/資本比率
CSW
USPH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $24.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $21.0M |
| FCFマージンFCF / 売上 | 9.8% | 10.4% |
| 設備投資強度設備投資 / 売上 | 2.6% | 1.9% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 6.00× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $61.0M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフロー
CSW
USPH
| Q4 25 | $28.9M | $24.9M | ||
| Q3 25 | $61.8M | $19.9M | ||
| Q2 25 | $60.6M | $34.9M | ||
| Q1 25 | $27.3M | $-4.7M | ||
| Q4 24 | $11.6M | $19.4M | ||
| Q3 24 | $66.8M | $22.1M | ||
| Q2 24 | $62.7M | $29.0M | ||
| Q1 24 | $22.4M | $4.4M |
フリーキャッシュフロー
CSW
USPH
| Q4 25 | $22.7M | $21.0M | ||
| Q3 25 | $58.7M | $15.6M | ||
| Q2 25 | $57.7M | $31.6M | ||
| Q1 25 | $22.8M | $-7.3M | ||
| Q4 24 | $8.5M | $16.9M | ||
| Q3 24 | $61.3M | $19.6M | ||
| Q2 24 | $59.6M | $26.7M | ||
| Q1 24 | $17.5M | $2.6M |
FCFマージン
CSW
USPH
| Q4 25 | 9.8% | 10.4% | ||
| Q3 25 | 21.2% | 7.9% | ||
| Q2 25 | 21.9% | 16.0% | ||
| Q1 25 | 9.9% | -3.9% | ||
| Q4 24 | 4.4% | 9.4% | ||
| Q3 24 | 26.9% | 11.7% | ||
| Q2 24 | 26.3% | 15.9% | ||
| Q1 24 | 8.3% | 1.7% |
設備投資強度
CSW
USPH
| Q4 25 | 2.6% | 1.9% | ||
| Q3 25 | 1.1% | 2.2% | ||
| Q2 25 | 1.1% | 1.6% | ||
| Q1 25 | 2.0% | 1.4% | ||
| Q4 24 | 1.6% | 1.4% | ||
| Q3 24 | 2.4% | 1.5% | ||
| Q2 24 | 1.4% | 1.4% | ||
| Q1 24 | 2.3% | 1.2% |
キャッシュ転換率
CSW
USPH
| Q4 25 | 2.81× | 6.00× | ||
| Q3 25 | 1.52× | 1.52× | ||
| Q2 25 | 1.48× | 2.81× | ||
| Q1 25 | 0.78× | -0.47× | ||
| Q4 24 | 0.43× | 2.10× | ||
| Q3 24 | 1.85× | 3.34× | ||
| Q2 24 | 1.62× | 3.86× | ||
| Q1 24 | 0.71× | 0.55× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
USPH
| Net Patient Revenues | $169.7M | 84% |
| Industrial Injury Prevention Services Revenues | $28.9M | 14% |
| Management Contract Revenues | $2.3M | 1% |